Norganoid develops the Nano-Lab-On-A-Chip, an advanced organ-on-chip device specifically designed for discovering and developing drugs to treat neurological disorders.

NORGANOID provides a pioneering organ-on-a-chip platform, enabling accelerated drug screening and development. The state-of-the-art technologies of stem cell research, microfluidics and nanotechnology are combined in the Nano-Lab-On-A-Chip system that helps to drastically reduce time and costs associated with medical and pharmaceutical research.

Charlotte Ohonin
Charlotte Ohonin, CEO of Norganoid

Sign up for our newsletter to stay up to date on community news, project highlights and upcoming events.